Intellectual and Experimental Due Diligence

Provid has unique experience in rapidly performing both intellectual and experimental scientific due diligence on early-stage opportunities to support “go/no-go” assessments and portfolio management decisions.

Clients for diligence studies:

  • Investors
  • Individual companies
  • Acquisition and licensing teams
  • Technology transfer departments
  • VC firms
  • Hedge funds

These clients have turned to Provid for confidential, timely, succinct, and candid assessment of such opportunities.

Provid understands that, with the cost of drug development and extent of failures driving spiraling industry expense, a definitive, well-supported go/no-go decision is immensely valuable to allow a client to deploy resources appropriately.